HC Wainwright Increases Dyne Therapeutics (NASDAQ:DYN) Price Target to $55.00

Dyne Therapeutics (NASDAQ:DYN – Get Free Report) had its price target hoisted by stock analysts at HC Wainwright from $48.00 to $55.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s target price indicates a potential upside of 25.34% from the stock’s current […]

Leave a Reply

Your email address will not be published.

Previous post Wells Fargo & Company Boosts Celldex Therapeutics (NASDAQ:CLDX) Price Target to $37.00
Next post Cintas (NASDAQ:CTAS) Research Coverage Started at Wells Fargo & Company